ÀǾàǰ À§Å¹ »ý»ê(CMO) ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, ¾÷°è µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)
Pharmaceutical Contract Manufacturing Organization (CMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
»óǰÄÚµå : 1687122
¸®¼­Ä¡»ç : Mordor Intelligence Pvt Ltd
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,601,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,296,000
PDF & Excel (Team License: Up to 7 Users) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷³» 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,500 £Ü 9,033,000
PDF & Excel (Site License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏÇÑ Áö¸®Àû À§Ä¡¿¡ ÀÖ´Â »ç¾÷Àå³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,750 £Ü 12,160,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀǾàǰ À§Å¹ »ý»ê(CMO) ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 1,844¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ÀÎ 2025-2030³â CAGR 6.53%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 2,530¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Pharmaceutical Contract Manufacturing Organization(CMO)-Market-IMG1

¼±ÁøÀûÀÎ Á¦Á¶±â¼ú ¹× ÇÁ·Î¼¼½º°¡ CMO ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. CMO´Â ¿¬¼Ó Á¦Á¶ µî »õ·Î¿î ¾÷¹« Àü·«À» ÅëÇØ Á¦Á¶ ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈ­ÇÏ°í ³¶ºñ¿Í ºñ¿ëÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ½Å¾à ½ÂÀο¡¼­ Â÷ÁöÇÏ´Â ºñÁßÀÌ Áõ°¡Çϸ鼭 Á¦Á¶ ´É·ÂÀÌ ºÎÁ·ÇØÁö±â ½¬¿î Áß¼Ò ±Ô¸ð Á¦¾à»çµéÀº CMO°¡ »õ·Î¿î Á¦Á¶ ±â¼úÀ» äÅÃÇÏ´Â ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

ÀǾàǰ À§Å¹ »ý»ê(CMO) ½ÃÀå µ¿Çâ

¿ø¾à(API)°ú Áß°£Ã¼ ¼ö¿ä´Â °ßÁ¶ÇÏ°Ô ÃßÀÌÇÒ Àü¸Á

ºÏ¹Ì°¡ ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇÒ Àü¸Á

ÀǾàǰ À§Å¹ »ý»ê(CMO) ½ÃÀå °³¿ä

Á¶»ç ´ë»ó ½ÃÀåÀº ¸Å¿ì ¼¼ºÐÈ­µÇ¾î ÀÖÀ¸¸ç ´ëÇü º¥´õ°¡ ½ÃÀå Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå¿¡ ¸¹Àº Âü°¡ ±â¾÷ÀÌ Á¸ÀçÇÏ´Â °ÍÀº ¼­ºñ½ºÀÇ °¡°Ý ¼³Á¤¿¡ ¿µÇâÀ» ÁÖ¸ç, ƯÈ÷ ¼Ò±Ô¸ð º¥´õ¿¡ À־´Â Á÷Á¢ÀûÀÎ °æÀï ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¶»ç ´ë»ó ½ÃÀåÀÇ º¥´õ´Â ¿ø½ºÅé ¼ó ¼­ºñ½º Á¦°ø¿¡ ÁÖ·ÂÇÏ¿© °æÀï»óÀÇ ¿ìÀ§¼ºÀ» ȹµæÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¹æ½ÄÀº ´ëÀÚº»¿¡ Á¢±ÙÇÒ ¼ö ÀÖ´Â CMO¶ó¸é °¡´ÉÇÏ´Ù°í »ý°¢µË´Ï´Ù. ÀÌ ¿äÀÎÀº °æÀïÀ» °ÝÈ­½ÃŰ°í ½Å±Ô Âü°¡ ±â¾÷ÀÇ ÁøÀÔ À庮ÀÌ µË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Patheon Inc.(Thermo Fisher Scientific Inc.),Lonza Group, Catalant Inc., Pfizer CentreOne(Pfizer Inc.), Boehringer Ingelheim Group µîÀÌ ÀÖ½À´Ï´Ù.

±âŸ ÇýÅÃ

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå ¿ªÇÐ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå °æÀï ±¸µµ

Á¦8Àå ¿¹Á¤µÈ ÀǾàǰÀ» Á¦Á¶ÇÏ´Â ¼³ºñ¸¦ °¡Áø ÁÖ¿ä CMOS ºÐ¼®

Á¦9Àå ÅõÀÚ ºÐ¼®

Á¦10Àå ½ÃÀå Àü¸Á

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Pharmaceutical Contract Manufacturing Organization Market size is estimated at USD 184.44 billion in 2025, and is expected to reach USD 253.05 billion by 2030, at a CAGR of 6.53% during the forecast period (2025-2030).

Pharmaceutical Contract Manufacturing Organization (CMO) - Market - IMG1

Advanced manufacturing technologies and processes are expected to contribute to the growth of the CMO market. CMOs can optimize their manufacturing processes and reduce waste and costs through new operational strategies, including continuous manufacturing. Small and mid-sized pharma companies, which account for an increasing share of new drug approvals and often lack manufacturing capacity, are expected to drive CMOs to adopt new manufacturing technologies.

Key Highlights

Pharmaceutical Contract Manufacturing Organization (CMO) Market Trends

Active Pharmaceutical Ingredient (API) and Intermediates are Expected to Witness Robust Demand

North America is expected to Hold a Significant Share in the Market

Pharmaceutical Contract Manufacturing Organization (CMO) Market Overview

The market studied is highly fragmented, with major vendors accounting for most of the market share. The presence of many players in the market impacts the pricing of services, making it a direct competing factor, especially for small-scale vendors. The vendors in the market studied are expected to focus on providing one-stop-shop services, providing them with a competitive advantage. These practices would be possible for CMOs with access to large capital. This factor increases the competition and creates a new players' entry barrier. Some of the major players in the market are Patheon Inc. (Thermo Fisher Scientific Inc.), Lonza Group, Catalant Inc., Pfizer CentreOne (Pfizer Inc.), and Boehringer Ingelheim Group.

Additional Benefits:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

5 MARKET DYNAMICS

6 MARKET SEGMENTATION

7 COMPETITIVE LANDSCAPE

8 ANALYSIS OF MAJOR CMOS WHO ARE EQUIPPED TO MANUFACTURE SCHEDULED DRUGS

9 INVESTMENT ANALYSIS

10 FUTURE OUTLOOK OF THE MARKET

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â